Antoni, S., Soerjomataram, I., Moore, S., Ferlay, J., Sitas, F., Smith, D. P. and Forman, D. (2014), The ban on phenacetin is associated with changes in the incidence trends of upper-urinary tract cancers in Australia. Australian and New Zealand Journal of Public Health. doi: 10.1111/1753-6405.12252

1. The ban on phenacetin is associated with changes in the incidence
trends of upper-urinary tract cancers in Australia
http://onlinelibrary.wiley.com/doi/10.1111/1753-6405.12252/full
Antoni, S., Soerjomataram, I., Moore, S., Ferlay, J., Sitas, F., Smith, D. P. and Forman,
D. (2014), The ban on phenacetin is associated with changes in the incidence trends
of upper-urinary tract cancers in Australia. Australian and New Zealand Journal of
Public Health. doi: 10.1111/1753-6405.12252
The authors have stated they have no conflict of interest.
Abstract
Background: Phenacetin is an analgesic that causes renal diseases and cancers of
the upper-urinary tract (UUT). It was banned in most countries from the late 1960s.
This study aimed to evaluate, for the first time, the long-term population impact of the
phenacetin ban on UUT cancer rates.
Methods: We used cancer registry data from Australia, where phenacetin was widely
used, to study age- and sex-specific incidence trends of cancers of the renal pelvis
and the ureter after the phenacetin ban (1979). Incidence rate ratios and average
annual percentage change (AAPC) were calculated to quantify changes in rates over
time.
Results: Incidence rates of renal pelvis cancer decreased by 52% in women and 39%
in men between 1983–1987 and 2003–2007. The decline in women was stronger in
states where the use of phenacetin was the most widespread, e.g. New South Wales
(AAPC: −4.1%; 95% CI −5.3, –2.9) and Queensland (AAPC: −3.3%; 95% CI −4.9,
−1.8), and after the mid-1990s. Incidence rates of ureteral cancer remained stable for
both sexes throughout the study period.
Conclusions: Our findings strongly suggest a beneficial impact of the ban on
phenacetin on the incidence of renal pelvis cancer in Australia, particularly among
women.
Cancer Council
NSW
ABN: 51 116 463 846
153 Dowling Street
Woolloomooloo NSW 2011
PO Box 572 Kings Cross NSW 1340
T: 02 9334 1900
F: 02 8302 3500
E: feedback@nswcc.org.au
Cancer Council
Helpline 13 11 20
cancercouncil.com.au
Cancer Epidemiology Research Unit